Clinical features of late‐onset Pompe disease: A prospective cohort study
暂无分享,去创建一个
A. Pestronk | L. H. van den Berg | K. Jaffe | P. Laforêt | J. Wokke | G. Carter | D. Escolar | D. Corzo | J. Florence | A. Skrinar | J. Mayhew
[1] M. Ausems,et al. Broad spectrum of Pompe disease in patients with the same c.-32-13T→G haplotype , 2007, Neurology.
[2] R. McCarter,et al. Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy , 2007, Muscle & nerve.
[3] G. Herman,et al. Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease. , 2006, The Journal of pediatrics.
[4] Wuh-Liang Hwu,et al. A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. , 2006, The Journal of pediatrics.
[5] J. Hankinson,et al. Interpretative strategies for lung function tests , 2005, European Respiratory Journal.
[6] A. Pestronk,et al. CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy , 2005, Annals of neurology.
[7] W. Hop,et al. Disease severity in children and adults with Pompe disease related to age and disease duration , 2005, Neurology.
[8] W. Hop,et al. Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients. , 2005, Brain : a journal of neurology.
[9] T. Voit,et al. Enzyme replacement therapy in classical infantile pompe disease: results of a ten-month follow-up study. , 2005, Neuropediatrics.
[10] A. Janssens,et al. Late-onset Pompe disease primarily affects quality of life in physical health domains , 2004, Neurology.
[11] R. Howell,et al. Pompe disease in infants and children. , 2004, The Journal of pediatrics.
[12] W. Hop,et al. Enzyme replacement therapy in late‐onset Pompe's disease: A three‐year follow‐up , 2004, Annals of neurology.
[13] D. V. Leenen,et al. Twenty‐two novel mutations in the lysosomal α‐glucosidase gene (GAA) underscore the genotype–phenotype correlation in glycogen storage disease type II , 2004, Human mutation.
[14] W. Hop,et al. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. , 2003, Pediatrics.
[15] E. Hoffman,et al. Collaborative translational research leading to multicenter clinical trials in Duchenne muscular dystrophy: the Cooperative International Neuromuscular Research Group (CINRG) , 2002, Neuromuscular Disorders.
[16] B. Byrne,et al. Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease). , 2002, Current molecular medicine.
[17] T. Voit,et al. Sleep-disordered breathing and respiratory failure in acid maltase deficiency , 2001, Neurology.
[18] A. Gulsvik,et al. Fev(6) as a surrogate for FVC: authors should have included ROC-curve analyses. , 2001, American journal of respiratory and critical care medicine.
[19] D. Escolar,et al. Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children , 2001, Muscle & nerve.
[20] L. Wilkins,et al. Activate your online subscription , 2001, Neurology.
[21] S. Spector,et al. A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM , 2001, Neurology.
[22] P. Laforêt,et al. Juvenile and adult-onset acid maltase deficiency in France , 2000, Neurology.
[23] M. Ausems,et al. Phenotypic expression of late-onset glycogen storage disease type II: identification of asymptomatic adults through family studies and review of reported families , 2000, Neuromuscular Disorders.
[24] P. Weiner,et al. The cumulative effect of long-acting bronchodilators, exercise, and inspiratory muscle training on the perception of dyspnea in patients with advanced COPD. , 2000, Chest.
[25] A. Amalfitano,et al. Towards a molecular therapy for glycogen storage disease type II (Pompe disease). , 2000, Molecular medicine today.
[26] S J Jay,et al. Reference equations for the six-minute walk in healthy adults. , 2000 .
[27] G. Criner,et al. Prospective Randomized Trial Comparing Bilateral Lung Volume Reduction Surgery to Pulmonary Rehabilitation in Severe Chronic Obstructive Pulmonary Disease , 1999 .
[28] A. Reuser,et al. A diagnostic protocol for adult-onset glycogen storage disease type II , 1999, Neurology.
[29] D L Sherrill,et al. Reference equations for the six-minute walk in healthy adults. , 1998, American journal of respiratory and critical care medicine.
[30] P. Paggiaro,et al. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease , 1998, The Lancet.
[31] National-Isometric-Muscle-Strength-Database-Consor. Muscular weakness assessment: use of normal isometric strength data. The National Isometric Muscle Strength (NIMS) Database Consortium. , 1996, Archives of physical medicine and rehabilitation.
[32] A. Reuser,et al. Genotype‐phenotype correlation in adult‐onset acid maltase deficiency , 1995, Annals of neurology.
[33] T. Mets,et al. Captopril treatment of chronic heart failure in the very old. , 1994, Journal of gerontology.
[34] A. Miller,et al. Lung function testing: selection of reference values and interpretative strategies. , 1992, The American review of respiratory disease.
[35] S. Chinn,et al. Portable liquid oxygen and exercise ability in severe respiratory disability. , 1992, Thorax.
[36] C. Sherbourne,et al. The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .
[37] J. Miller,et al. Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. , 1989, The New England journal of medicine.
[38] P. Trend,et al. Acid maltase deficiency in adults. Diagnosis and management in five cases. , 1985, Brain : a journal of neurology.
[39] M. Brooke,et al. Clinical trial in duchenne dystrophy. I. The design of the protocol , 1981, Muscle & nerve.
[40] G. Herman,et al. CHINESE HAMSTER OVARY CELL-DERIVED RECOMBINANT HUMAN ACID α -GLUCOSIDASE IN INFANTILE-ONSET POMPE DISEASE , 2009 .
[41] ATS statement: guidelines for the six-minute walk test. , 2002, American journal of respiratory and critical care medicine.
[42] J L Hankinson,et al. Spirometric reference values from a sample of the general U.S. population. , 1999, American journal of respiratory and critical care medicine.
[43] A. Reuser,et al. Glycogenosis type II (acid maltase deficiency) , 1995, Muscle & nerve. Supplement.
[44] Ware J.E.Jr.,et al. THE MOS 36- ITEM SHORT FORM HEALTH SURVEY (SF- 36) CONCEPTUAL FRAMEWORK AND ITEM SELECTION , 1992 .
[45] M. Province,et al. Clinical trials in Duchenne dystrophy. Standardization and reliability of evaluation procedures. , 1984, Physical therapy.
[46] L. F. Black,et al. Maximal respiratory pressures: normal values and relationship to age and sex. , 1969, The American review of respiratory disease.